Evidence map›Paper›PMID 32175108›Full record

ArticleJournal of gastrointestinal oncology2020

Liver-first approach to stage IV colon cancer with synchronous isolated liver metastases.

Vadim Kurbatov, Benjamin J Resio, Cara A Cama, Danielle R Heller, Charles Cha, Yawei Zhang, Jun Lu, Sajid A Khan

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vadim KurbatovDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Benjamin J ResioDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Cara A CamaDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Danielle R HellerDepartment of Surgery, Yale School of Medicine, New Haven, CT, USA.
Charles ChaSection of Surgical Oncology, Yale School of Medicine, New Haven, CT, USA.
Yawei ZhangSection of Surgical Outcomes and Epidemiology, Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
Jun LuDepartment of Genetics, Yale School of Medicine, New Haven, CT, USA.
Sajid A KhanSection of Surgical Oncology, Yale School of Medicine, New Haven, CT, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundThe only possibility for cure in patients with colon adenocarcinoma (CAC) with isolated liver metastases (ILM) is resection of both primary and metastatic tumors. Little is known about the implication of the sequence in which a colectomy and hepatectomy are performed on outcomes. This study analyzes whether resection sequence impacts clinical outcomes.

methodsThe National Cancer Database was queried for CAC cases with hepatic metastases from 2010-2015 with exclusion of extrahepatic metastases. We compared patients treated with a liver-first approach (LFA) to those treated with a colectomy-first or simultaneous approach using Kaplan Meier and multivariable Cox proportional hazards analysis.

resultsIn 21,788 CAC patients identified, the LFA was uncommon (2%), but was associated with higher rates of completion resection of remaining tumor (41%

conclusionsThe LFA to CAC with synchronous ILM is uncommon but is associated with greater likelihood of receiving chemotherapy prior to surgery and increased survival in selected candidates.

Indexed as

colon adenocarcinoma (CAC)hepatectomyliver-firstMetastasismetastatectomyNational Cancer Data Base (NCDB)

Identifiers

PMID32175108
PMCPMC7052756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.